你即將離開本站

並前往https://www.oncozine.com/nccn-guidelines-to-recommend-siltuximab-for-patients-with-imcd-plasmacytic-or-mixed-histology/

NCCN® Guidelines to Recommend Siltuximab for Patients ...

Updated NCCN® Clinical Practice Guidelines Recommend Siltuximab (Sylvant) for the treatment of Patients with iMCD Plasmacytic or Mixed ...

確定！ 回上一頁

查詢 「NCCN guideline 2021」的人也找了：

  1. NCCN guideline 2021 Lung Cancer
    2.
  2. NCCN guideline 2021
    3.
  3. nccn guideline 2021中文
    4.
  4. Nccn guideline 2021 pdf
    5.
  5. NCCN Guideline 2021 breast Cancer
    6.
  6. NCCN 2021
    7.
  7. NCCN guideline 2021 nsclc
    8.
  8. NCCN guideline 2020
    9.